Back to top

GlaxoSmithKline (GSK) Receives a Sell from Barclays

In a report released today, James Gordon CFA from Barclays maintained a Sell rating on GlaxoSmithKline, with a price target of £19.00. According to...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

GSK PLC Sponsored ADR (GSK)